A recent study has reported that TEPP-46, a well-characterized allosteric activator of PKM2, inhibits the pathogenicity of macrophages, DCs, T cells, and tumor cells [39,40], suggesting that inhibition of PKM2 has the potential to influence the TIME. Here, PKM is linked to neoplasm.